[REGN] YoY Quarter Result on 30-Jun-2015 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Aug-2015
Financial Year
2015
Quarter
30-Jun-2015 [#Q2]
Profit Trend
QoQ- 156.04%
YoY- 109.89%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 1,608,022 1,470,116 1,212,629 998,617 665,700 457,642 304,399 31.95%
PBT 656,074 525,850 292,256 327,996 203,119 147,692 76,743 42.97%
Tax 104,662 138,106 96,038 133,353 110,384 60,316 -501 -
NP 551,412 387,744 196,218 194,643 92,735 87,376 76,743 38.89%
Tax Rate -15.95% -26.26% -32.86% -40.66% -54.34% -40.84% 0.65% -
Total Cost 1,056,610 1,082,372 1,016,411 803,974 572,965 370,266 227,656 29.13%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin 34.29 26.38 16.18 19.49 13.93 19.09 25.21 5.25%
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
EPS 5.12 3.66 1.88 1.89 0.96 0.89 0.81 35.95%
EPS Diluted 4.82 3.34 1.69 1.69 0.85 0.79 0.70 37.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.